Series A

SoftBank led a $103m series B round for the internet-of-things network and hub developer that made up one of two rounds it has raised.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

GV was among the investors as long-term care support provider CareBridge emerged from stealth with $40m and two acquisitions.

CareCentrix, Nationwide and existing backer Kaiser Permanente all chipped in as the homecare support services provider secured $30m.

GV and Nextech are among the participants in a series A round that is funding the launch of EQRx, which is developing cheaper copies of existing drugs.

The remittance services startup raised $31.2m from backers including HashKey, UOB, Seven Bank, Uni-President Enterprises and Hanwha.

Mayo Clinic has bet on chronic disease drug developer Novome Biotechnologies, which is initially targeting a disorder known as hyperoxaluria.

Roche Venture Fund led a $14.1m extension for Jasper Therapeutics, developer of a conditioning agent for haematopoietic cell transplants, boosting the round to more than $49m.